JTCS Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fish, K. J.
Right arrow Articles by Tinklenberg, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fish, K. J.
Right arrow Articles by Tinklenberg, J. S.

The Journal of Thoracic and Cardiovascular Surgery, Vol 93, 609-615, Copyright © 1987 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

A prospective, randomized study of the effects of prostacyclin on neuropsychologic dysfunction after coronary artery operation

KJ Fish, KN Helms, FH Sarnquist, C van Steennis, OI Linet, M Hilberman, RS Mitchell, SW Jamieson, DC Miller and JS Tinklenberg

This randomized, double-blind study was designed to evaluate the effect of prostacyclin (epoprostenol) on the incidence and severity of postoperative neuropsychologic dysfunction in patients undergoing coronary artery operation. Four days before operation and 1 week after operation, 100 patients having coronary artery bypass grafting underwent detailed neurologic and psychologic examinations and computed tomographic scans of the brain. The psychologic examination was repeated 2 months after operation. During cardiopulmonary bypass, all patients received 300 U/kg of heparin and then either buffer-diluent or prostacyclin (12.5 ng/kg/min from the time of heparinization until onset of cardiopulmonary bypass and 25 ng/kg/min during cardiopulmonary bypass). No deaths or major neurologic complications occurred in this series. Ninety-six patients completed the psychologic and neurologic evaluations 1 week after operation; 74 of these patients were evaluated psychologically 2 months after operation. Psychologic testing demonstrated similar declines in postoperative performance in both the prostacyclin-treated and the control groups; these changes were no longer present in either group 2 months after operation. Results of neurologic examinations and computed tomographic scans of the brain were unchanged. We conclude that the administration of prostacyclin during cardiopulmonary bypass in patients undergoing routine coronary artery operation has no effect on perioperative cognitive changes.


This article has been cited by other articles:


Home page
Anesth. Analg.Home page
G. S. Murphy, E. A. Hessel II, and R. C. Groom
Optimal Perfusion During Cardiopulmonary Bypass: An Evidence-Based Approach
Anesth. Analg., May 1, 2009; 108(5): 1394 - 1417.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
Y. Kadoi
Pharmacological Neuroprotection During Cardiac Surgery
Asian Cardiovasc Thorac Ann, April 1, 2007; 15(2): 167 - 177.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
I. Szalma, A. Kiss, L. Kardos, G. Horvath, E. Nyitrai, Z. Tordai, and L. Csiba
Piracetam prevents cognitive decline in coronary artery bypass: a randomized trial versus placebo.
Ann. Thorac. Surg., October 1, 2006; 82(4): 1430 - 1435.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
J. Butterworth and J. W. Hammon
Lidocaine for Neuroprotection: More Evidence of Efficacy
Anesth. Analg., November 1, 2002; 95(5): 1131 - 1133.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. Orihashi, Y. Matsuura, T. Sueda, H. Shikata, M. Watari, and K. Okada
Clinical implication of orbital ultrasound monitoring during selective cerebral perfusion
Ann. Thorac. Surg., February 1, 2001; 71(2): 673 - 677.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
D. van Dijk, A. M. A. Keizer, J. C. Diephuis, C. Durand, L. J. Vos, and R. Hijman
Neurocognitive dysfunction after coronary artery bypass surgery: A systematic review
J. Thorac. Cardiovasc. Surg., October 1, 2000; 120(4): 632 - 639.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
S NEWMAN and J STYGALL
Changes in cognition following cardiac surgery
Heart, November 1, 1999; 82(5): 541 - 542.
[Full Text]


Home page
Ann. Thorac. Surg.Home page
E. P. Mahanna, J. A. Blumenthal, W. D. White, N. D. Croughwell, C. P. Clancy, L. R. Smith, and M. F. Newman
Defining Neuropsychological Dysfunction After Coronary Artery Bypass Grafting
Ann. Thorac. Surg., May 1, 1996; 61(5): 1342 - 1347.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
M. F. Newman, N. D. Croughwell, J. A. Blumenthal, E. Lowry, W. D. White, W. Spillane, R. D. Davis Jr, D. D. Glower, L. R. Smith, E. P. Mahanna, et al.
Predictors of Cognitive Decline After Cardiac Operation
Ann. Thorac. Surg., May 1, 1995; 59(5): 1326 - 1330.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
G. E. Venn, R. L. Patel, and D. J. Chambers
Cardiopulmonary Bypass: Perioperative Cerebral Blood Flow and Postoperative Cognitive Deficit
Ann. Thorac. Surg., May 1, 1995; 59(5): 1331 - 1335.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
J. A. Blumenthal, E. P. Mahanna, D. J. Madden, W. D. White, N. D. Croughwell, and M. F. Newman
Methodological Issues in the Assessment of Neuropsychologic Function After Cardiac Surgery
Ann. Thorac. Surg., May 1, 1995; 59(5): 1345 - 1350.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1987 by The American Association for Thoracic Surgery.